Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8

Yoichi Ohba, Yuso Goto, Yusuke Kimura, Fujio Suzuki, Tomoyuki Hisa, Kojiro Takahashi, Masaharu Takigawa

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

We previously reported that a novel human chondrosarcoma-derived chondrocytic cell line, HCS-2/8, produced an anti-tumor angiogenesis factor and secreted it into the culture medium [Takigawa et al.: Anticancer Res., 10, 311-316, 1990]. In the present study, we purified the inhibitor by monitoring gelatinase inhibitory activity from the conditioned medium (CM) of HCS-2/8 cells. By a simple three-step procedure, gel filtration chromatography, ion-exchange chromatography, and reverse-phase HPLC, 200 μg of the inhibitor was obtained from 6 liters of CM with 239-fold enrichment. Purified inhibitor, named hCHIAMP (human chondrocyte-derived inhibitor of angiogenesis and metalloproteinase activity), showed a single protein band with a molecular mass (Mr) of 24 000 (24K) under reducing conditions and Mr 22K under nonreducing conditions on SDS-PAGE. On reverse-zymography, purified hCHIAMP showed a single band of 22K Mr under nonreducing conditions. Its NH2-terminal amino acid sequence determined up to the 11th amino acid residue was identical with that of the tissue inhibitor of metalloproteinases-2 (TIMP-2). On Western blotting, anti-human TIMP-2 antibody cross-reacted with hCHIAMP. hCHIAMP at a dose of as little as 0.45 μg significantly inhibited angiogenesis in the yolk sac of chick embryos induced by 0.25 μmol of spermine. Because HCS-2/8 is a clonal cell line, these findings clearly showed for the first time that chondrocytes themselves produce a potent inhibitor of angiogenesis, which is also an inhibitor of gelatinase. The findings also indicate that hCHIAMP is a TIMP-2-like molecule. Because the HCS-2/8 cells are an immortal cell line and of human origin, hCHIAMP could be useful for therapy of angiogenic diseases including solid tumors.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalBiochimica et Biophysica Acta - General Subjects
Volume1245
Issue number1
DOIs
Publication statusPublished - Aug 17 1995

Fingerprint

Chondrosarcoma
Angiogenesis Inhibitors
Conditioned Culture Medium
Metalloproteases
Chondrocytes
Purification
Cells
Cell Line
Tissue Inhibitor of Metalloproteinase-2
Matrix Metalloproteinase Inhibitors
Tumors
Amino Acids
Spermine
Angiogenesis Inducing Agents
Yolk Sac
Molecular mass
Chromatography
Ion Exchange Chromatography
Chick Embryo
Culture Media

Keywords

  • Angiogenesis
  • Cartilage
  • Chondrocyte
  • Gelatinase
  • Matrix metalloproteinase
  • Tissue inhibitor
  • Yolk-sac

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8. / Ohba, Yoichi; Goto, Yuso; Kimura, Yusuke; Suzuki, Fujio; Hisa, Tomoyuki; Takahashi, Kojiro; Takigawa, Masaharu.

In: Biochimica et Biophysica Acta - General Subjects, Vol. 1245, No. 1, 17.08.1995, p. 1-8.

Research output: Contribution to journalArticle

Ohba, Yoichi ; Goto, Yuso ; Kimura, Yusuke ; Suzuki, Fujio ; Hisa, Tomoyuki ; Takahashi, Kojiro ; Takigawa, Masaharu. / Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8. In: Biochimica et Biophysica Acta - General Subjects. 1995 ; Vol. 1245, No. 1. pp. 1-8.
@article{f12239e3e83147a194c3af9a42c3c24a,
title = "Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8",
abstract = "We previously reported that a novel human chondrosarcoma-derived chondrocytic cell line, HCS-2/8, produced an anti-tumor angiogenesis factor and secreted it into the culture medium [Takigawa et al.: Anticancer Res., 10, 311-316, 1990]. In the present study, we purified the inhibitor by monitoring gelatinase inhibitory activity from the conditioned medium (CM) of HCS-2/8 cells. By a simple three-step procedure, gel filtration chromatography, ion-exchange chromatography, and reverse-phase HPLC, 200 μg of the inhibitor was obtained from 6 liters of CM with 239-fold enrichment. Purified inhibitor, named hCHIAMP (human chondrocyte-derived inhibitor of angiogenesis and metalloproteinase activity), showed a single protein band with a molecular mass (Mr) of 24 000 (24K) under reducing conditions and Mr 22K under nonreducing conditions on SDS-PAGE. On reverse-zymography, purified hCHIAMP showed a single band of 22K Mr under nonreducing conditions. Its NH2-terminal amino acid sequence determined up to the 11th amino acid residue was identical with that of the tissue inhibitor of metalloproteinases-2 (TIMP-2). On Western blotting, anti-human TIMP-2 antibody cross-reacted with hCHIAMP. hCHIAMP at a dose of as little as 0.45 μg significantly inhibited angiogenesis in the yolk sac of chick embryos induced by 0.25 μmol of spermine. Because HCS-2/8 is a clonal cell line, these findings clearly showed for the first time that chondrocytes themselves produce a potent inhibitor of angiogenesis, which is also an inhibitor of gelatinase. The findings also indicate that hCHIAMP is a TIMP-2-like molecule. Because the HCS-2/8 cells are an immortal cell line and of human origin, hCHIAMP could be useful for therapy of angiogenic diseases including solid tumors.",
keywords = "Angiogenesis, Cartilage, Chondrocyte, Gelatinase, Matrix metalloproteinase, Tissue inhibitor, Yolk-sac",
author = "Yoichi Ohba and Yuso Goto and Yusuke Kimura and Fujio Suzuki and Tomoyuki Hisa and Kojiro Takahashi and Masaharu Takigawa",
year = "1995",
month = "8",
day = "17",
doi = "10.1016/0304-4165(95)00065-J",
language = "English",
volume = "1245",
pages = "1--8",
journal = "Biochimica et Biophysica Acta - General Subjects",
issn = "0304-4165",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8

AU - Ohba, Yoichi

AU - Goto, Yuso

AU - Kimura, Yusuke

AU - Suzuki, Fujio

AU - Hisa, Tomoyuki

AU - Takahashi, Kojiro

AU - Takigawa, Masaharu

PY - 1995/8/17

Y1 - 1995/8/17

N2 - We previously reported that a novel human chondrosarcoma-derived chondrocytic cell line, HCS-2/8, produced an anti-tumor angiogenesis factor and secreted it into the culture medium [Takigawa et al.: Anticancer Res., 10, 311-316, 1990]. In the present study, we purified the inhibitor by monitoring gelatinase inhibitory activity from the conditioned medium (CM) of HCS-2/8 cells. By a simple three-step procedure, gel filtration chromatography, ion-exchange chromatography, and reverse-phase HPLC, 200 μg of the inhibitor was obtained from 6 liters of CM with 239-fold enrichment. Purified inhibitor, named hCHIAMP (human chondrocyte-derived inhibitor of angiogenesis and metalloproteinase activity), showed a single protein band with a molecular mass (Mr) of 24 000 (24K) under reducing conditions and Mr 22K under nonreducing conditions on SDS-PAGE. On reverse-zymography, purified hCHIAMP showed a single band of 22K Mr under nonreducing conditions. Its NH2-terminal amino acid sequence determined up to the 11th amino acid residue was identical with that of the tissue inhibitor of metalloproteinases-2 (TIMP-2). On Western blotting, anti-human TIMP-2 antibody cross-reacted with hCHIAMP. hCHIAMP at a dose of as little as 0.45 μg significantly inhibited angiogenesis in the yolk sac of chick embryos induced by 0.25 μmol of spermine. Because HCS-2/8 is a clonal cell line, these findings clearly showed for the first time that chondrocytes themselves produce a potent inhibitor of angiogenesis, which is also an inhibitor of gelatinase. The findings also indicate that hCHIAMP is a TIMP-2-like molecule. Because the HCS-2/8 cells are an immortal cell line and of human origin, hCHIAMP could be useful for therapy of angiogenic diseases including solid tumors.

AB - We previously reported that a novel human chondrosarcoma-derived chondrocytic cell line, HCS-2/8, produced an anti-tumor angiogenesis factor and secreted it into the culture medium [Takigawa et al.: Anticancer Res., 10, 311-316, 1990]. In the present study, we purified the inhibitor by monitoring gelatinase inhibitory activity from the conditioned medium (CM) of HCS-2/8 cells. By a simple three-step procedure, gel filtration chromatography, ion-exchange chromatography, and reverse-phase HPLC, 200 μg of the inhibitor was obtained from 6 liters of CM with 239-fold enrichment. Purified inhibitor, named hCHIAMP (human chondrocyte-derived inhibitor of angiogenesis and metalloproteinase activity), showed a single protein band with a molecular mass (Mr) of 24 000 (24K) under reducing conditions and Mr 22K under nonreducing conditions on SDS-PAGE. On reverse-zymography, purified hCHIAMP showed a single band of 22K Mr under nonreducing conditions. Its NH2-terminal amino acid sequence determined up to the 11th amino acid residue was identical with that of the tissue inhibitor of metalloproteinases-2 (TIMP-2). On Western blotting, anti-human TIMP-2 antibody cross-reacted with hCHIAMP. hCHIAMP at a dose of as little as 0.45 μg significantly inhibited angiogenesis in the yolk sac of chick embryos induced by 0.25 μmol of spermine. Because HCS-2/8 is a clonal cell line, these findings clearly showed for the first time that chondrocytes themselves produce a potent inhibitor of angiogenesis, which is also an inhibitor of gelatinase. The findings also indicate that hCHIAMP is a TIMP-2-like molecule. Because the HCS-2/8 cells are an immortal cell line and of human origin, hCHIAMP could be useful for therapy of angiogenic diseases including solid tumors.

KW - Angiogenesis

KW - Cartilage

KW - Chondrocyte

KW - Gelatinase

KW - Matrix metalloproteinase

KW - Tissue inhibitor

KW - Yolk-sac

UR - http://www.scopus.com/inward/record.url?scp=0029150408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029150408&partnerID=8YFLogxK

U2 - 10.1016/0304-4165(95)00065-J

DO - 10.1016/0304-4165(95)00065-J

M3 - Article

C2 - 7544625

AN - SCOPUS:0029150408

VL - 1245

SP - 1

EP - 8

JO - Biochimica et Biophysica Acta - General Subjects

JF - Biochimica et Biophysica Acta - General Subjects

SN - 0304-4165

IS - 1

ER -